Understanding the causes of Adult T-cell leukemia/lymphoma

Pathophysiology of Adult T-cell leukemia/lymphoma

NIH-funded research Rlr VA Medical Center · NIH-11098413

This study is looking at Adult T-cell leukemia/lymphoma, a tough cancer that often hits young adults, especially veterans, to find out why some patients don’t respond well to treatment and how we can make those treatments better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRlr VA Medical Center NIH-funded
Lab location1 site (Indianapolis, United States)
Project IDNIH-11098413 on NIH RePORTER

What this research studies

This research investigates Adult T-cell leukemia/lymphoma (T-ALL), a severe form of cancer that often affects young adults, particularly veterans. The focus is on understanding the underlying mechanisms that lead to treatment resistance and relapse in patients. By studying specific cancer cells that survive chemotherapy, the research aims to identify new therapeutic targets to improve treatment outcomes. The approach includes biochemical characterization of key oncogenes involved in the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults diagnosed with T-cell acute lymphoblastic leukemia, particularly those who have experienced treatment resistance.

Not a fit: Patients with other types of leukemia or those who do not have T-cell acute lymphoblastic leukemia may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for Adult T-cell leukemia/lymphoma, potentially improving survival rates and quality of life for patients.

How similar studies have performed: Previous research has shown promise in targeting similar oncogenes in other aggressive leukemias, suggesting that this approach may be effective.

Where this research is happening

Indianapolis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.